Streetbeat News

Stock Prices

ABT

EW

FDA advisors will discuss Abbott Laboratories' TriClip G4 System for severe tricuspid regurgitation (TR) on February 13, 2024. Despite the TRILUMINATE trial meeting its primary endpoint, FDA reviewers raised concerns about the trial's unblinded design and the potential placebo effect on patient-reported outcomes. Earlier, Edwards Lifesciences received FDA approval for its Evoque tricuspid valve replacement system without an advisory committee, based on positive TRISCEND II study results. ABT shares fell 0.38% to $111.38.

Portfolio Pulse from Vandana Singh

February 12, 2024 | 4:00 pm

ASML

INTC

SSNLF

TSM

ASML Holding NV showcased its advanced €350 million chipmaking machine, ordered by Intel Corp for its Oregon factory, aiming for production by late 2025. This machine, critical for AI advancements, etches semiconductor lines as thin as 8 nanometers. ASML's technology has seen record orders, including from Samsung Electronics and Taiwan Semiconductor Manufacturing Co, reflecting strong industry optimism. ASML reported a 12.5% year-on-year increase in Q4 2023 net sales, with China being its largest market.

Portfolio Pulse from Anusuya Lahiri

February 12, 2024 | 3:58 pm

VFC

VF Corporation's stock (VFC) is experiencing an uptick after reports emerged that activist investor Engaged Capital has garnered backing from the company's founding family. This development suggests potential changes in the company's strategy or management, which investors are reacting positively to.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:57 pm

AMZN

GOOG

META

PINS

SNAP

Snap Inc. (SNAP) stock plummeted nearly a third after Q4 results missed Wall Street expectations and announced a 10% workforce reduction. Despite solid user growth, Snap's revenue per user fell, contrasting with the online ad market recovery seen by Meta Platforms (META), Alphabet (GOOG), and Amazon.com Inc. (AMZN), who reported significant ad revenue growth. Pinterest (PINS) also faced monetization challenges, seeking partnerships with Google and Amazon for improvement. Snap aims to focus on growing its user base and engagement in monetizable markets.

Portfolio Pulse from Upwallstreet

February 12, 2024 | 3:56 pm

RNLX

Shares of Renalytix (RNLX) were temporarily halted due to a circuit breaker triggered by a significant downside movement. Despite this, the stock is currently up by 188.6%.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:55 pm

RNLX

Trading of Renalytix (RNLX) shares has resumed after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:53 pm

SGMO

Sangamo Therapeutics' stock is trading higher following the announcement of FDA alignment on an abbreviated pathway for potential approval and EMA PRIME eligibility for its ST-920 treatment in Fabry disease.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:51 pm

RNLX

Renalytix shares experienced a significant surge, leading to a trading halt due to a circuit breaker trigger. The stock is currently up by 212.3%.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:49 pm

BIG

Big Lots shares dropped following preliminary Q4 results and a downgrade by Loop Capital from Hold to Sell, with a price target reduction from $6 to $1.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:48 pm

TOP

TOP Financial Group Ltd (NASDAQ:TOP) shares plummeted 35.8% to $3.46 after announcing a sale of 2 million shares and warrants at below-market prices, aiming for $5 million in gross proceeds. The deal, facilitated by Univest Securities, LLC, is set to close around February 14. The article also discusses the importance of capital allocation programs and mentions Cornerstone Strategic's dividend yield opportunity.

Portfolio Pulse from Henry Khederian

February 12, 2024 | 3:47 pm